The eye clinic says most people on GLP-1 weight loss drugs don't need extra eye checks, but any vision changes are worth noticing.
Recap by typeshit. Post by @moorfields_private on Instagram.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
The Ministry of Health and Social Services wants careful prescribing and monitoring as public demand for weight loss and metabolic treatments grows.
Our Peak says skin can lag behind when people lose a lot of weight quickly on GLP-1 drugs, since it needs time to remodel.
Loading…